Clinical Trials Directory

Trials / Completed

CompletedNCT00989599

Use of Chamomilla Recutita in Phlebitis

Therapeutic Topic Use of Chamomilla Recutita in Phlebitis Due to Peripheral Intravenous Therapy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
123 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To verify the efficacy of topical applications of Chamomilla recutita infusion for phlebitis treatment, before dose response curve study and pilot study.

Detailed description

The hypothesis adopted was that patients with phlebitis due to peripheral intravenous infusion in anti-neoplasm chemotherapy, treated with a compress of Chamomilla recutita infusion for 20 minutes three times per day, would present a shorter phlebitis regression time in comparison with patients treated with a lukewarm water compress.

Conditions

Interventions

TypeNameDescription
OTHERcompress of Chamomilla recutita infusionPatients with phlebitis due to peripheral intravenous infusion in anti-neoplasm chemotherapy were treated with a compress of Chamomilla recutita infusion for 20 minutes three times per day
OTHERcompress of lukewarm waterPatients with phlebitis due to peripheral intravenous infusion in anti-neoplasm chemotherapy, in control group, were treated with a compress of lukewarm water for 20 minutes three times per day

Timeline

Start date
2004-09-01
Primary completion
2007-12-01
Completion
2008-09-01
First posted
2009-10-05
Last updated
2009-10-05

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00989599. Inclusion in this directory is not an endorsement.